CJMB (Callan JMB Inc) Market Value to Book Value Ratio

Callan JMB Inc (CJMB) creates a closed-loop ecosystem by integrating surgical instrumentation with physician training. However, geopolitical instability and sanctions complicate component logistics and restrict exports. Consistent trust from medical professionals reinforces its status as a niche player. The historical relationship between market cap and book value demonstrates financial resilience, where 3.99 represents the latest metric reading.

CJMB - callanjmb.com Market-to-Book Ratio over the range 02/06/2025 - 10/27/2026

CJMB (Callan JMB Inc): analytical breakdowns and indicator data

- price and consensus price forecast:
Stock Price callanjmb.com|CJMB - Price Target Chart
- market capitalization data:
Market Value Callan JMB Corp|CJMB - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Callan JMB|CJMB - Total Stockholders' Equity|Market Capitalization to Book Value Ratio callanjmb.com|CJMB - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Callan JMB Inc|CJMB - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital callanjmb.com|CJMB - Company Total Debt|Debts to Book Capitalization Callan JMB Corp
Initial company analysis:Callan JMB Inc. - CJMB

This indicator determines the market premium over the company's net equity. By analyzing the relative capitalization of the company, an investor can see the current business valuation relative to its book value. The metric compares the market value of shares with equity to identify if the asset is overbought. The stability of this ratio for Callan JMB Inc (CJMB) is supported by regular revenues from consumables. A high share of repeat sales offsets the risks associated with narrow specialization in surgery.

Direct competitors

Intuitive Surgical (ISRG) - Market Capitalization to Book Value Ratio|DHR (danaher.com) - Market Value to Book Value Ratio|Market Value to Book Value Ratio BDX|Market Cap to Net Assets Ratio STERIS PLC|West Pharmaceutical Services Inc - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Baxter Healthcare (BAX)|MASI - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio stevanatogroup.com STVN|Market Capitalization to Book Value Ratio TFX (Teleflex)|MMSI - Market Capitalization to Book Value|NVST (Envista Holdings Corp) - Market Capitalization to Book Value Ratio|ICU Medical Inc. (ICUI) - Market Cap to Net Assets Ratio|XRAY (DENTSPLY SIRONA Inc.) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio LMAT|Market Value to Book Value Ratio AtriCure (ATRC)|Market Value to Book Value Ratio STAAR Surgical Co. STAA|Market Cap to Net Assets Ratio niagenbioscience.com|Market Value to Book Value ZimVie Corp ZIMV|Market Capitalization to Book Value Ratio ANGO (AngioDynamics, Inc.)|CERS: Market Capitalization to Book Value|Market Value to Book Value Ratio Teknova|MGRM (Monogram Technologies Inc.) - Capitalization to Book Value Ratio|STSS: Market Value to Book Value Ratio|Market Capitalization to Book Value InfuSystem Inc (INFU)|Market Cap to Net Assets Ratio Utah Medical Products|Market Cap to Book Value Multiple KRMD (korumedical.com)|Market Value to Book Value Ratio Nyxoah|MBOT - Market Value to Book Value|Pro-Dex Corp - Market Cap to Net Assets Ratio|ZTEK: Market Capitalization to Book Value Ratio|ELUT (Elutia Inc.) - Market Value to Book Value Ratio|milestonescientific.com (MLSS) - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio NXGL (NEXGEL)|Market-to-Book Ratio RVP|Market Value to Book Value Ratio Harvard Bioscience HBIO|Capitalization to Book Value Ratio Femasys Corporation FEMY|Market Cap to Net Assets Ratio Meihua Medical Technologies Co., Ltd. (MHUA)|Predictive Oncology Inc - Market Cap to Book Value Multiple|Market Value to Book Value Ratio ATRI (Atrion)|NURO - Market Capitalization to Book Value